Most Cited & Viewed

Most Cited & Viewed Papers

Views Article
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
by Stefania C. Carrara, David Fiebig, Jan P. Bogen, Julius Grzeschik, Björn Hock and Harald Kolmar
Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
by Brian A. Baldo
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective
by Andrew T. Lucas, Amber Moody, Allison N. Schorzman and William C. Zamboni
New Opportunities in Glycan Engineering for Therapeutic Proteins
by Xiaotian Zhong, Aaron M. D’Antona, John J. Scarcelli and Jason C. Rouse
Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics
by Taihei Murakami, Shigefumi Kumachi, Yasuhiro Matsunaga, Miwa Sato, Kanako Wakabayashi-Nakao, Hidekazu Masaki, Ryo Yonehara, Maiko Motohashi, Naoto Nemoto and Masayuki Tsuchiya
Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
by J. Edward Fisher, Jr.
Persistent Hyper IgA as a Marker of Immune Deficiency: A Case Report
by Russell J. Hopp and Hana B. Niebur
Introduction to Antibody-Drug Conjugates
by Mark C. Pettinato
Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers
by Uwe Reusch, Kristina Ellwanger, Ivica Fucek, Thomas Müller, Ute Schniegler-Mattox, Joachim Koch and Michael Tesar
Clinical Pharmacology of Antibody-Drug Conjugates
by Iftekhar Mahmood
Downloads Article
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
by Stefania C. Carrara, David Fiebig, Jan P. Bogen, Julius Grzeschik, Björn Hock and Harald Kolmar
Clinical Pharmacology of Antibody-Drug Conjugates
by Iftekhar Mahmood
Introduction to Antibody-Drug Conjugates
by Mark C. Pettinato
Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
by J. Edward Fisher, Jr.
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy
by Yasmin Jenkins, Joanna Zabkiewicz, Oliver Ottmann and Nicholas Jones
A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting
by Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa
Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer
by Violet Y. Tu, Asma Ayari and Roddy S. O’Connor
The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
by Rita Tavarozzi and Enrica Manzato
Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
by Brian A. Baldo
Back to TopTop